Amyloid: The Journal of Protein Folding Disorders This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 20, 2021 Category: Biochemistry Authors: Benjamin J. Van Treeck Surendra Dasari Paul J. Kurtin Jason D. Theis Samih H. Nasr Lizhi Zhang Saba Yasir Rondell P. Graham Ellen D. McPhail Samar Said Source Type: research

Fixed duration vs. prolonged duration treatment after first line therapy in patients with systemic light chain amyloidosis
Volume 29, Issue 1, March 2022, Page 23-30 . (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 14, 2021 Category: Biochemistry Authors: Alfonso Rivera Duarte Donna Reece Xuan Li Wei Xu Harminder Paul Esther Masih-Khan Andrew Winter Rodger Tiedemann Anca Prica Christine Chen Suzanne Trudel Vishal Kukreti Source Type: research

Fixed duration vs. prolonged duration treatment after first line therapy in patients with systemic light chain amyloidosis
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 14, 2021 Category: Biochemistry Authors: Alfonso Rivera Duarte Donna Reece Xuan Li Wei Xu Harminder Paul Esther Masih-Khan Andrew Winter Rodger Tiedemann Anca Prica Christine Chen Suzanne Trudel Vishal Kukreti Source Type: research

In search of the most effective therapy for light chain amyloidosis
Volume 29, Issue 1, March 2022, Page 67-68 . (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 13, 2021 Category: Biochemistry Authors: Giovanni Palladini Paolo Milani Giampaolo Merlini Source Type: research

Management of AL amyloidosis in 2021+
Volume 29, Issue 1, March 2022, Page 66-66 . (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 13, 2021 Category: Biochemistry Authors: Alan Solomon Source Type: research

In search of the most effective therapy for light chain amyloidosis
Volume 29, Issue 1, March 2022, Page 67-68 . (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 13, 2021 Category: Biochemistry Authors: Giovanni Palladini Paolo Milani Giampaolo Merlini Source Type: research

Management of AL amyloidosis in 2021+
Volume 29, Issue 1, March 2022, Page 66-66 . (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 13, 2021 Category: Biochemistry Authors: Alan Solomon Source Type: research

In search of the most effective therapy for light chain amyloidosis
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 13, 2021 Category: Biochemistry Authors: Giovanni Palladini Paolo Milani Giampaolo Merlini Source Type: research

Management of AL amyloidosis in 2021+
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 13, 2021 Category: Biochemistry Authors: Alan Solomon Source Type: research

Progressive vitreous deposits during treatment with inotersen for hereditary ATTR amyloidosis
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 9, 2021 Category: Biochemistry Authors: Jo ão Heitor Marques Jo ão Coelho Maria Jo ão Menéres Jo ão Melo Beirão Source Type: research

Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - September 1, 2021 Category: Biochemistry Authors: Efstathios Kastritis Pantelis Rousakis Ioannis V. Kostopoulos Maria Gavriatopoulou Foteini Theodorakakou Despina Fotiou Ioanna Dialoupi Magdalini Migkou Maria Roussou Nikolaos Kanellias Maria-Irini Tselegkidi Evangelos Eleutherakis-Papaiakovou Asimina Pap Source Type: research

Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - August 16, 2021 Category: Biochemistry Authors: Giuseppe Vergaro Alberto Aimo Alessandro Campora Vincenzo Castiglione Concetta Prontera Silvia Masotti Veronica Musetti Michela Chianca Alessandro Valleggi Valentina Spini Michele Emdin Claudio Passino Source Type: research

Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis
. (Source: Amyloid: The Journal of Protein Folding Disorders)
Source: Amyloid: The Journal of Protein Folding Disorders - August 11, 2021 Category: Biochemistry Authors: Sunil E. Saith Danilo Gamino Sergio Teruya Samantha Guadalupe Stephen Helmke Jeffeny De Los Santos Jeff Goldsmith Hannah R. Rosenblum Jan M. Griffin Mathew S. Maurer Source Type: research